Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07101341 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Acute Effects of Aerobic Exercise and High-intensity Interval Exercise With Immersive Virtual Reality

StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

  1. Notable Trial status: Not Yet Recruiting to Recruiting
    • Primary and study completion dates: Dec 2026 to Jun 2027
    • Start date changed from estimate of Jan 2026 to Feb 25, 2026
    • Site details revised
    v3
  2. Notable Primary and study completion dates: Feb 2026 to Dec 2026
    • Start date: Sep 2025 to Jan 2026
    v2
  3. Minor Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This study aims to compare the acute effects at the cardiovascular (heart rate, blood pressure) and physiological (lactate) levels, as well as the perception of effort and fatigue, of four exercise modalities, one based on the traditional aerobic training methodology, another based on high-intensity interval training (HIIT), another consisting of aerobic exercise performed in conjunction with an immersive virtual reality (VR) application, and a last one consisting of exercise with HIIT-type parameters but also performed in conjunction with an immersive VR application. All participants will complete one session of each of the four exercise modalities, analyzing the variables studied in each for subsequent analysis and comparison.
Trial Details
NCT Number NCT07101341
Lead Sponsor University of Valencia
Conditions
(from sponsor)
Acute Effects of Exercise in Healthy People, Health Adult Subjects
Enrollment 45 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov